BILIRUBIN ANALYZER MARKET

INTRODUCTION TOBILIRUBIN ANALYZER MARKET

Red-orange chemical bilirubin (BR), sometimes known as "red bile," is produced by the usual catabolic process used by vertebrates to break down heme. The body needs to go through this catabolism in order to get rid of waste products that result from the oxidation of old or dysfunctional red blood cells.

The heme molecule is separated from the hemoglobin molecule in the initial phase of the bilirubin production process. The steps of porphyrin catabolism that heme goes through next vary depending on the part of the body where the breakdown takes place. For instance, the chemicals expelled in pee and feces are different.

The first significant step in the catabolic process is the synthesis of biliverdin from heme, and the second step is carried out by the enzyme biliverdin reductase, which creates bilirubin from biliverdin.

Elevated amounts of bilirubin, which is ultimately broken down by the body and expelled as metabolites in the urine and bile, may signify certain disorders. It is in charge of both the yellow discoloration in jaundice and the color of healed injuries.

Its breakdown products, such as stercobilin, are what give feces their brown hue. Urobilin, a separate breakdown product, is what gives urine its straw-yellow hue.

Even though bilirubin is often only found in mammals, one plant species, Strelitzia Nicolai, has been shown to have the pigment.

A bilirubin analyzer is a tool for measuring bilirubin levels and is frequently used in neonatal intensive care units to check for jaundice in newborns. The analyzers either assess skin reflectance or measure bilirubin levels in blood or serum samples, which essentially removes the costs, discomfort, and time associated with blood draws. 

BILIRUBIN ANALYZER MARKET SIZE AND FORECAST

The Global Bilirubin Analyzer market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

BILIRUBIN ANALYZER MARKETNEW PRODUCT LAUNCH

Neonate bilirubin test results from the new OMNI S bilirubin analyzer are available in seconds.

It used to be virtually entirely the responsibility of the busy lab personnel who spend their days operating the huge clinical chemistry analyzers in a hospital's high-volume central laboratory to screen and swiftly diagnose neonates with increased and dangerous levels of bilirubin.

Now that hospitals concentrating on critical care near patient testing continue to invest in the OMNI S analyzer, the most recent addition to the OMNI blood gas analyzer line produced and distributed by Roche Diagnostics, testing methodology is quickly evolving.

BILIRUBIN ANALYZER MARKETCOMPANY PROFILE

• Roche Diagnostics
• APEL
• David Medical Device
• Siemens Healthineers AG
• Ningbo David Medical Device
• Dragerwerk

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS OFBILIRUBIN ANALYZER MARKET

1. How many Bilirubin Analyzer are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a  Global Bilirubin Analyzer and key vendor selection criteria
3. Where is the Bilirubin Analyzer manufactured? What is the average margin per unit?
4. Market share of Global Bilirubin Analyzer  manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Bilirubin Analyzer in-house
6. 5 key predictions for next 5 years in Global Bilirubin Analyzer
7. Average B-2-B Bilirubin Analyzer price in all segments
8. Latest trends in Bilirubin Analyzer, by every market segment
9. The market size (both volume and value) of the Bilirubin Analyzer in 2024-2030 and every year in between?
10. Production breakup of Bilirubin Analyzer, by suppliers and their OEM relationship